Biotech · Public company · San Diego, CA, US

Ligand Pharmaceuticals Inc

Ticker LGND · SEC CIK 0000886163

Track this companyFree. Adds Ligand Pharmaceuticals Inc to your Dealase workspace and tells you when its record changes.

Clinical trials40 recruiting or active

Pipeline programs0None found yet

Disclosed deals0None found yet

Cash runwayNot availableNo recent cash burn filed

Clinical trials4

Activity of NCO-48 Fumarate in Treatment-Naive Adults With Chronic Hepatitis BPHASE1 · COMPLETED · started Jan 12, 2021ClinicalTrials.gov NCT04629976 · fetched Nov 12, 2026
Safety, Tolerability and Pharmacokinetics of NCO-48 Fumarate in Healthy SubjectsPHASE1 · COMPLETED · started Mar 18, 2020ClinicalTrials.gov NCT04309526 · fetched Nov 12, 2026
A Phase I/II Study of Bexarotene in Combination With ZD1839 (IRESSA®) in the Treatment of Non-Small Cell Lung CancerPHASE1_PHASE2 · COMPLETED · started Apr 1, 2004ClinicalTrials.gov NCT00238628 · fetched Nov 12, 2026
Erlotinib (Tarceva) and Bexarotene (Targretin) Oral Capsules in Advanced Cancers of the Aerodigestive TractPHASE1 · COMPLETED · started Apr 1, 2003ClinicalTrials.gov NCT01116622 · fetched Nov 12, 2026